Related Experiment Videos
Special considerations in the therapy of diabetic hypertension
1Division of Endocrinology, Metabolism and Hypertension, Wayne State University School of Medicine, Detroit, MI 48201, USA.
Insights
Diabetic patients with hypertension face higher cardiovascular disease (CVD) risks. Early, aggressive treatment of high blood pressure is crucial despite potential medication challenges in diabetes management.
Area of Science:
- Cardiology
- Endocrinology
- Pharmacology
Background:
- Diabetes mellitus (DM) significantly increases the prevalence of hypertension and cardiovascular disease (CVD).
- The coexistence of DM and hypertension magnifies CVD risk, often exacerbated by dyslipidemia and coagulation abnormalities.
- Metabolic disturbances like insulin resistance and impaired fibrinolysis are common in hypertensive diabetic individuals.
Purpose of the Study:
- To review the efficacy and side effects of various antihypertensive medication classes in patients with diabetes mellitus.
- To highlight the challenges in managing hypertension in diabetic patients.
- To emphasize the importance of early and aggressive hypertension management in diabetes.
Main Methods:
- Review of existing literature on antihypertensive agents in diabetic populations.
- Analysis of drug efficacy, side effects, and impact on glycemic and lipid control.
- Synthesis of information regarding the management of hypertension in the context of diabetes.
Main Results:
- Antihypertensive drug efficacy can be altered in diabetic patients.
- Potential side effects include worsening glycemic control and lipid metabolism impairment.
- Despite challenges, early and aggressive hypertension treatment is vital for reducing morbidity and mortality.
Conclusions:
- Hypertension management in diabetes is complex due to altered drug efficacy and metabolic interactions.
- Careful selection of antihypertensive agents is necessary to balance blood pressure control with metabolic considerations.
- Aggressive treatment of hypertension is essential for mitigating cardiovascular risks in patients with diabetes mellitus.
Abstract:
Patients with diabetes mellitus have an increased prevalence of hypertension and associated cardiovascular disease (CVD), including coronary and cerebrovascular disease. The risk of an individual of developing CVD is much greater when both diseases coexist and is further magnified by their frequent association with dyslipidemia, coagulation, platelet, and endothelial abnormalities. Metabolic abnormalities frequently associated with hypertension are insulin resistance, enhanced coagulation, and decreased fibrinolytic activity. Drug treatment of hypertension in diabetic subjects is fraught with potential difficulties, including altered efficacy of medications, possible side effects, worsening of glycemic control, and impairment of lipid metabolism. Because hypertension is a major contributor to morbidity and mortality in diabetes, it should be recognized and treated early and aggressively despite these difficulties. This article reviews the efficacy and side effects of the various classes of antihypertensive agents in patients with diabetes mellitus.